VRTX FY2025 SEC EDGAR DEF 14A #53 of 168 in industry

Vertex Pharmaceuticals Inc / Ma CEO pay ratio

The CEO earned $21.1M in FY2025 against median worker pay of $264,303 · Chemicals & Pharmaceuticals.

Chemicals & Pharmaceuticals peers All rankings
State
MA
Filing date
2026-04-02
Industry
Chemicals & Pharmaceuticals
Industry rank
#53/168

Data updated August 2026

Subscribe to Vertex Pharmaceuticals Inc / Ma CEO pay filing updates (RSS)

CEO-to-worker pay ratio
80:1
Moderate (Scale: 0–1000:1)
CEO pay
$21.1M
Median worker
$264,303

Answer first

Vertex Pharmaceuticals Inc / Ma's FY2025 CEO total of $21.1M ranks #156 of 1,423 complete filings; its 80:1 pay ratio ranks #772. Dollar rank is not ratio rank.

According to the same FY2025 complete-filing cohort used on the rankings boards (CEO total, median worker, and ratio all present). Median worker pay is $264,303. Industry placement uses the FY2025 SIC-28 peer cohort (# 53 of 168, 69th percentile - above the industry median pay ratio). Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Chemicals & Pharmaceuticals companies.

Dollar rank
#156
$21.1M of 1,423 FY2025
Ratio rank
#772
80:1 of 1,423
Industry pct
69th
above the industry median pay ratio

How Vertex Pharmaceuticals Inc / Ma ranks nationally

Vertex Pharmaceuticals Inc / Ma CEO pay vs. every FY2025 complete filing

Total CEO compensation, the full national distribution, this company marked

$21,144,261 Top 11% higher than 89% of 1,423 companies

$0–$2,500,000: 304 companies (21%). Below this entry. $2,500,000–$5,000,000: 182 companies (13%). Below this entry. $5,000,000–$7,500,000: 208 companies (15%). Below this entry. $7,500,000–$10,000,000: 192 companies (13%). Below this entry. $10,000,000–$12,500,000: 139 companies (10%). Below this entry. $12,500,000–$15,000,000: 91 companies (6%). Below this entry. $15,000,000–$17,500,000: 88 companies (6%). Below this entry. $17,500,000–$20,000,000: 54 companies (4%). Below this entry. $20,000,000–$22,500,000: 24 companies (2%). This entry sits in this band. $22,500,000–$25,000,000: 34 companies (2%). Above this entry. $25,000,000–$27,500,000: 24 companies (2%). Above this entry. $27,500,000–$30,000,000: 16 companies (1%). Above this entry. $30,000,000–$32,500,000: 10 companies (1%). Above this entry. $32,500,000–$35,000,000: 7 companies (0%). Above this entry. $35,000,000–$37,500,000: 9 companies (1%). Above this entry. $37,500,000–$40,000,000: 6 companies (0%). Above this entry. $40,000,000–$42,500,000: 1 companies (0%). Above this entry. $42,500,000–$45,000,000: 1 companies (0%). Above this entry. $45,000,000–$47,500,000: 6 companies (0%). Above this entry. $47,500,000–$50,000,000: 27 companies (2%). Above this entry. This company $0 $50M+ every complete-filing company, bucketed by value

Each bar is a $2500K-wide band; taller bars hold more companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source SEC DEF 14A Section 953(b) disclosures, PlainCEOPay extract · FY2025

Vertex Pharmaceuticals Inc / Ma vs. Chemicals & Pharmaceuticals peers

CEO total pay ($21.1M) against pay ratio (80:1) for Vertex Pharmaceuticals Inc / Ma (marked) and its 5 closest same-industry peers, against the Chemicals & Pharmaceuticals industry median on both axes.

Pay + gap both highContained pay, wide gapHigh pay, contained gapBelow peer norms on both5051956.89266607.91348125917695910.121910561.239.9:151.7:163.5:175.3:187.2:1CEO total payPay ratio (CEO : median worker)Vertex Pharmaceuticals Inc / Ma, CEO total pay: 21144261 · Pay ratio (CEO : median worker): 80:1Vertex Pharmaceuticals Inc / MaSupernus Pharmaceuticals, Inc., CEO total pay: 15501556 · Pay ratio (CEO : median worker): 81:1Supernus Pharmaceuticals, Inc.Lantheus Holdings, Inc., CEO total pay: 15346066 · Pay ratio (CEO : median worker): 79:1Lantheus Holdings, Inc.Repligen Corp, CEO total pay: 6114771 · Pay ratio (CEO : median worker): 82:1Repligen CorpUNITED THERAPEUTICS Corp, CEO total pay: 18042856 · Pay ratio (CEO : median worker): 76:1UNITED THERAPEUTICS CorpAvient Corp, CEO total pay: 5818257 · Pay ratio (CEO : median worker): 85:1Avient Corp
Vertex Pharmaceuticals Inc / Ma vs. Chemicals & Pharmaceuticals peers, plotted against the industry's $7.9M median CEO total and 42:1 median pay ratio.

Ratio bands among Chemicals & Pharmaceuticals peers

Exclusive CEO-to-median-worker bands across 153 complete latest-FY filings in SIC 28. Segments sum to the peer set, not this company's compensation pillar.

CEO Compensation Breakdown, FY2025

A component-level pay breakdown is not reported in Vertex Pharmaceuticals Inc / Ma's structured SEC pay-ratio disclosure. See our methodology →

Filing-year trail · Vertex Pharmaceuticals Inc / Ma

Complete DEF 14A pay-ratio filings for this CIK across FY2021–2025. Year-over-year deltas compare adjacent filing years only; incomplete dollar rows are omitted (same completeness gate as the hero figures).

Latest ratio
80:1
FY2025
vs prior FY
-8:1
from FY2024 88:1
CEO $ YoY
-1.8%
$21.1M latest
Filings shown
5
FY2021–2025
Vertex Pharmaceuticals Inc / Ma CEO total compensation, median worker pay, and pay ratio by fiscal year from SEC EDGAR DEF 14A.
FY CEO pay Δ pay Median worker Pay ratio Δ ratio
2021 $15.2M - $234,107 65:1 -
2022 $15.9M +4.3% $240,371 66:1 +1:1
2023 $20.6M +30% $248,126 83:1 +17:1
2024 $21.5M +4.6% $244,758 88:1 +5:1
2025 $21.1M -1.8% $264,303 80:1 -8:1

Source: SEC EDGAR DEF 14A pay-ratio disclosures for CIK 875320, FY2021–2025. Adjacent-year deltas only.

Industry Comparison - Chemicals & Pharmaceuticals

This Company's Ratio
80:1
Industry Median Ratio
42:1
Industry Median CEO Pay
$7.9M
This CEO's Pay
$21.1M
Companies in Industry
168
vs. Industry Median
Above
#53 of 168 by pay ratio in this industry View all companies in Chemicals & Pharmaceuticals →

Vertex Pharmaceuticals Inc / Ma: MID · PEAK pay ratio

Vertex Pharmaceuticals Inc / Ma's FY2025 CEO total $21.1M ranks #156 of 1,423 complete filings (higher third by dollars). the CEO earned 80× the median employee ($264,303) in FY2025.

Median employee $264,303 (ELITE-MED); MID · PEAK stamps put about 80 median-wage years per CEO year.

CEO Total Pay

$21.1M

FY2025 Summary Compensation, well above median

Pay Ratio

80:1

Near industry median

Vertex Pharmaceuticals Inc / Ma in the higher-dollar third

Vertex Pharmaceuticals Inc / Ma's FY2025 CEO total $21.1M ranks #156 of 1,423 complete filings (higher third by dollars). The structured pay-ratio disclosure reports the total without line-item components. Chemicals & Pharmaceuticals (SIC 28) median ratio is 42:1 across 168 FY2025 filers; Vertex Pharmaceuticals Inc / Ma's $21.1M CEO total is above the $7.9M industry median CEO pay.

Dollar rank #156 and ratio rank #772 split - treat 80:1 as a disclosure, not a fairness score. Open Chemicals & Pharmaceuticals peers.

Key Data, FY2025

Total Compensation
$21.1M
Median Employee Pay
$264,303
Pay Ratio
80:1
Filing Date
2026-04-02

Company Info

Ticker
VRTX
CIK
875320
Industry
Chemicals & Pharmaceuticals
SIC Code
2834
State
MA
View SEC filings →
SEC EDGAR DEF 14A for CIK 875320, FY2025. Informational only, not investment advice. Verify on EDGAR.

Read our methodology - how this data is sourced, computed, and verified. Vertex Pharmaceuticals Inc / Ma's FY2025 CEO total $21.1M ranks #156 of 1,423 complete filings (higher third by dollars).

Read with Vertex Pharmaceuticals Inc / Ma

ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps MID · PEAK · ELITE-MED.

Viking Therapeutics, Inc. · PEAK

ABS(ceo_total_comp) peer at $21.3M (Δ $126K heavier vs Vertex Pharmaceuticals Inc / Ma); MODEST · ELITE-MED vs this page's MID · PEAK · ELITE-MED.
Baker Hughes Co · PEAK

ABS(ceo_total_comp) peer at $21.3M (Δ $159K heavier vs Vertex Pharmaceuticals Inc / Ma); HIGH · PAR-MED vs this page's MID · PEAK · ELITE-MED.
Stryker Corp · PEAK

ABS(ceo_total_comp) peer at $21.4M (Δ $257K heavier vs Vertex Pharmaceuticals Inc / Ma); STEEP · HIGH-MED vs this page's MID · PEAK · ELITE-MED.
Targa Resources Corp. · PEAK

ABS(ceo_total_comp) peer at $21.4M (Δ $298K heavier vs Vertex Pharmaceuticals Inc / Ma); MID · ELITE-MED vs this page's MID · PEAK · ELITE-MED.
Supernus Pharmaceuticals, Inc. (SIC 28 pole)

Supernus Pharmaceuticals, Inc. stamps MID · PEAK nearest in-SIC by ABS(pay_ratio) to Vertex Pharmaceuticals Inc / Ma's MID filing.
National dual ranks · #156/#772

Vertex Pharmaceuticals Inc / Ma's FY2025 package sits #156 by CEO dollars and #772 by ratio under PEAK · MID.
Comp structure · PEAK

Vertex Pharmaceuticals Inc / Ma's PEAK CEO total is equity-sensitive - read what grant-date fair value does and does not mean.
Data sourced from SEC EDGAR DEF 14A for Vertex Pharmaceuticals Inc / Ma (CIK 875320), FY2025. See our methodology. Aggregated by PlainCEOPay as of August 2026.

Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.